Charles River Laboratories International, Inc. (CRL) Q1 2009 Earnings Results

Charles River Laboratories Beats on EPS, Stock Down 0.71%

Charles River Laboratories reported a better-than-expected EPS, which indicates solid performance in their operations. However, the stock fell by 0.71%, likely due to the lack of revenue data and guidance, leaving investors uncertain about future performance. The cautious tone from management may have also contributed to the stock's decline.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.58	N/A	+9.85%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed a positive outlook on their core business despite not providing specific guidance. They emphasized their commitment to growth and efficiency.

Management highlighted strong performance in core segments.

They noted ongoing investments in innovation and capacity expansion.

Focus remains on maintaining operational efficiency.

Charles River Laboratories Beats on EPS, Stock Down 0.71%

Key numbers

Management commentary

Charles River Laboratories International, Inc.

More earnings this week

Charles River Laboratories Beats on EPS, Stock Down 0.71%

Key numbers

Management commentary